• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.53% Nasdaq Down0.70%

    More On CXR.TO



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Concordia Healthcare Corp. (CXR.TO)

    92.30 Up 0.31(0.34%) 1:35PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Concordia Healthcare Corp.
    277 Lakeshore Road East
    Suite 302
    Oakville, ON L6J 1H9
    Canada - Map
    Phone: 905-842-5150
    Fax: 905-842-5154
    Website: http://www.concordiarx.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Concordia Healthcare Corp. operates as an integrated healthcare company that focuses on legacy pharmaceutical products and orphan drugs for the diabetic market. The company operates through three divisions: Legacy Pharmaceuticals, Specialty Healthcare Distribution, and Orphan Drugs. The Legacy Pharmaceuticals division offers Kapvay, a clonidine extended release tablet used for the treatment of attention-deficit hyperactivity disorder; Ulesfia Lotion, a white topical lotion containing benzyl alcohol, for the treatment of head lice infestation; Orapred ODT, a prednisolone sodium phosphate orally disintegrating tablet used in the treatment of various severe allergic reactions in children; Donnatal, an adjunctive therapy for the treatment of irritable bowel syndrome and acute enterocolitis; and Zonegran for treatment of partial seizures in adults with epilepsy. The Specialty Healthcare Distribution division distributes diabetes testing supplies and other healthcare products, including diabetic testing supplies, wound care products, and urinary catheters. The Orphan Drugs division manufactures Photodynamic therapy with Photofrin for the treatment of cancer. Concordia Healthcare Corp. is headquartered in Oakville, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Concordia Healthcare Corp.

    Key Executives 
    Mr. Mark L. Thompson , 47
    Founder, Chairman and Chief Exec. Officer
    Mr. Wayne Walter Kreppner , 42
    Pres and Chief Operating Officer
    Mr. Robert Steven Altman Ph.D.,
    Pres of Pinnacle Biologics Inc
    Mr. John McCleery , 57
    Chief Financial Officer of Concordia Pharmaceuticals Inc, Chief Financial Officer of Concordia Laboratories Inc, Managing Director of Concordia Pharmaceuticals Inc and Managing Director of Concordia Laboratories Inc
    Mr. Adrian A. de Saldanha , 54
    Chief Financial Officer
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.